PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 17372243-7 2007 The most common CYP1B1 haplotype was Arg(48)-Ala(119)-Val(432)-Asn(453). Arginine 37-40 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 16-22 18573508-1 2008 In the present study, genotype and haplotype frequencies of four polymorphisms of cytochrome P450 1B1 (CYP1B1) that cause amino acid changes (Arg-Gly at codon 48, Ala-Ser at codon 119, Leu-Val at 432 and Asn-Ser at codon 453) were studied in 200 patients suffering from lung cancer and equal number of controls. Arginine 142-145 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 82-101 18573508-1 2008 In the present study, genotype and haplotype frequencies of four polymorphisms of cytochrome P450 1B1 (CYP1B1) that cause amino acid changes (Arg-Gly at codon 48, Ala-Ser at codon 119, Leu-Val at 432 and Asn-Ser at codon 453) were studied in 200 patients suffering from lung cancer and equal number of controls. Arginine 142-145 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 103-109 18067928-2 2008 In the present study, genotype and haplotype frequencies of four single nucleotide polymorphisms (SNPs) in CYP1B1 that cause amino acid changes (Arg-Gly at codon 48, Ala-Ser at codon 119, Leu-Val at codon 432 and Asn-Ser at codon 453) were studied in 150 cases suffering from head and neck squamous cell carcinoma (HNSCC) and in an equal number of controls. Arginine 145-148 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 107-113 15734954-5 2005 The common alleles of the CYP1B1 gene were Arg (79.97%) in codon 48, Ala (80.53%) in codon 119, and Leu (86.57%) in codon 432. Arginine 43-46 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 26-32 16569655-10 2006 The decreased risk we observed with the hOGG1 326 Cys/Cys genotype confirms an earlier report and the further reduced risk found with the CYP1B1 (432 Leu/Leu or Leu/Val)-hOGG1 (326 Cys/Cys)-XRCC1 (Arg/Arg or Arg/Gln) genotype combination may lend new insights to the importance of ROS generated from non-receptor-mediated estrogenic mechanisms in more aggressive prostate cancer. Arginine 197-200 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 138-144 16569655-10 2006 The decreased risk we observed with the hOGG1 326 Cys/Cys genotype confirms an earlier report and the further reduced risk found with the CYP1B1 (432 Leu/Leu or Leu/Val)-hOGG1 (326 Cys/Cys)-XRCC1 (Arg/Arg or Arg/Gln) genotype combination may lend new insights to the importance of ROS generated from non-receptor-mediated estrogenic mechanisms in more aggressive prostate cancer. Arginine 201-204 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 138-144 16569655-10 2006 The decreased risk we observed with the hOGG1 326 Cys/Cys genotype confirms an earlier report and the further reduced risk found with the CYP1B1 (432 Leu/Leu or Leu/Val)-hOGG1 (326 Cys/Cys)-XRCC1 (Arg/Arg or Arg/Gln) genotype combination may lend new insights to the importance of ROS generated from non-receptor-mediated estrogenic mechanisms in more aggressive prostate cancer. Arginine 201-204 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 138-144 15176218-5 2004 In the same patients, receptor-negative tumors occurred more often (p = 0.032) than in combinations of higher level of 4-hydroxylase estradiol of S-allele in position 48 (Gly/Arg) of the CYP1B1 gene. Arginine 175-178 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 187-193